Internal Medicine, Hematology & Oncology · Meridian, ID
NPI
1649534975
Since 2012
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
520 S Eagle Rd
Meridian, ID, 83642
Phone (208) 706-5651
Groups this clinician bills Medicare through
Medicare paid, 2024
$91K
1,118 services
Medicare patients, 2024
356
Average age 74
Drug cost, 2024
$3.5M
1,345 prescriptions
Company payments, 2025
$6,088
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sri Harsha Tella was code 99215 (office e&m - established), 353 times for 162 patients. In total Sri Harsha Tella billed 1,118 services in 14 codes, and Medicare paid $91K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 353 | 162 | $99.41 | $35K |
| 99215 Office E&M - Established | Office | 148 | 71 | $108.76 | $16K |
| 99214 Office E&M - Established | Facility | 147 | 109 | $69.54 | $10K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 109 | 70 | $23.12 | $2,520 |
| 99205 Office E&M - New | Facility | 84 | 84 | $127.50 | $11K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 57 | 32 | $24.27 | $1,384 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 52 | 46 | $5.65 | $294 |
| 99214 Office E&M - Established | Office | 42 | 26 | $72.79 | $3,057 |
| 99205 Office E&M - New | Office | 32 | 32 | $140.65 | $4,501 |
| 99233 Hospital E&M - Subsequent | Facility | 24 | 15 | $92.61 | $2,223 |
| 99223 Hospital E&M - Initial | Facility | 22 | 21 | $129.11 | $2,840 |
| G0316 Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 15 | 14 | $23.75 | $356 |
By year: 2022 $17K for 146 services; 2023 $26K for 240 services; 2024 $91K for 1,118 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sri Harsha Tella prescribed most often to Medicare patients was Prochlorperazine Maleate, with 119 prescriptions and refills. In total Sri Harsha Tella wrote 1,345 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prochlorperazine Maleate Generic | 119 | 121 | 69 | $1,399 |
| Ondansetron Odt Ondansetron | 106 | 106 | 68 | $2,053 |
| Prednisone Generic | 101 | 117 | 27 | $390 |
| Hydroxyurea Generic | 79 | 147 | 21 | $2,423 |
| Abiraterone Acetate Generic | 78 | 85 | 13 | $22K |
| Letrozole Generic | 77 | 195 | 34 | $1,987 |
| Tamoxifen Citrate Generic | 45 | 124 | 21 | $1,769 |
| Dexamethasone Generic | 42 | 43 | 19 | $710 |
| Oxycodone Hcl Generic | 36 | 36 | 19 | $221 |
| Eliquis Apixaban | 33 | 54 | 13 | $31K |
| Acyclovir Generic | 32 | 40 | Under 11 | $978 |
| Anastrozole Generic | 28 | 84 | Under 11 | $540 |
| Amlodipine Besylate Generic | 24 | 54 | Under 11 | $297 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 23 | 23 | 19 | $295 |
| Calquence Acalabrutinib Maleate | 23 | 23 | Under 11 | $330K |
Brand drugs: 265 claims; generic drugs: 1,080 claims; opioid claims: 64.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sri Harsha Tella $6,088 ($6,088 in general payments such as food, travel and fees) from 3 companies. The largest payer was Exelixis Inc. with $4,213.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.